BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Singh AP, Prabha V, Rishi P. Value addition in the efficacy of conventional antibiotics by Nisin against Salmonella. PLoS One 2013;8:e76844. [PMID: 24116175 DOI: 10.1371/journal.pone.0076844] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Carmona-Ribeiro AM, de Melo Carrasco LD. Novel formulations for antimicrobial peptides. Int J Mol Sci 2014;15:18040-83. [PMID: 25302615 DOI: 10.3390/ijms151018040] [Cited by in Crossref: 80] [Cited by in F6Publishing: 71] [Article Influence: 10.0] [Reference Citation Analysis]
2 Lee B, Lee DG. Synergistic antibacterial activity of gold nanoparticles caused by apoptosis-like death. J Appl Microbiol 2019;127:701-12. [PMID: 31216601 DOI: 10.1111/jam.14357] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
3 Jia Z, Chen A, Bao F, He M, Gao S, Xu J, Zhang X, Niu P, Wang C. Effect of nisin on microbiome-brain-gut axis neurochemicals by Escherichia coli -induced diarrhea in mice. Microbial Pathogenesis 2018;119:65-71. [DOI: 10.1016/j.micpath.2018.04.005] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
4 Mathur H, Field D, Rea MC, Cotter PD, Hill C, Ross RP. Bacteriocin-Antimicrobial Synergy: A Medical and Food Perspective. Front Microbiol 2017;8:1205. [PMID: 28706513 DOI: 10.3389/fmicb.2017.01205] [Cited by in Crossref: 81] [Cited by in F6Publishing: 70] [Article Influence: 16.2] [Reference Citation Analysis]
5 Rishi P, Preet Singh A, Garg N, Rishi M. Evaluation of nisin–β-lactam antibiotics against clinical strains of Salmonella enterica serovar Typhi. J Antibiot 2014;67:807-11. [DOI: 10.1038/ja.2014.75] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
6 Castelani L, Arcaro JRP, Braga JEP, Bosso AS, Moura Q, Esposito F, Sauter IP, Cortez M, Lincopan N. Short communication: Activity of nisin, lipid bilayer fragments and cationic nisin-lipid nanoparticles against multidrug-resistant Staphylococcus spp. isolated from bovine mastitis. J Dairy Sci 2019;102:678-83. [PMID: 30415844 DOI: 10.3168/jds.2018-15171] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
7 Nguyen T, Brody H, Lin GH, Rangé H, Kuraji R, Ye C, Kamarajan P, Radaic A, Gao L, Kapila Y. Probiotics, including nisin-based probiotics, improve clinical and microbial outcomes relevant to oral and systemic diseases. Periodontol 2000 2020;82:173-85. [PMID: 31850634 DOI: 10.1111/prd.12324] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 10.5] [Reference Citation Analysis]
8 Reinseth IS, Ovchinnikov KV, Tønnesen HH, Carlsen H, Diep DB. The Increasing Issue of Vancomycin-Resistant Enterococci and the Bacteriocin Solution. Probiotics Antimicrob Proteins 2020;12:1203-17. [PMID: 31758332 DOI: 10.1007/s12602-019-09618-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
9 Cavera VL, Arthur TD, Kashtanov D, Chikindas ML. Bacteriocins and their position in the next wave of conventional antibiotics. Int J Antimicrob Agents 2015;46:494-501. [PMID: 26341839 DOI: 10.1016/j.ijantimicag.2015.07.011] [Cited by in Crossref: 100] [Cited by in F6Publishing: 87] [Article Influence: 14.3] [Reference Citation Analysis]
10 Rishi P, Vij S, Maurya IK, Kaur UJ, Bharati S, Tewari R. Peptides as adjuvants for ampicillin and oxacillin against methicillin-resistant Staphylococcus aureus (MRSA). Microb Pathog 2018;124:11-20. [PMID: 30118800 DOI: 10.1016/j.micpath.2018.08.023] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
11 Ducarmon QR, Zwittink RD, Hornung BVH, van Schaik W, Young VB, Kuijper EJ. Gut Microbiota and Colonization Resistance against Bacterial Enteric Infection. Microbiol Mol Biol Rev 2019;83:e00007-19. [PMID: 31167904 DOI: 10.1128/MMBR.00007-19] [Cited by in Crossref: 78] [Cited by in F6Publishing: 48] [Article Influence: 26.0] [Reference Citation Analysis]
12 Kulshreshtha G, Critchley A, Rathgeber B, Stratton G, Banskota AH, Hafting J, Prithiviraj B. Antimicrobial Effects of Selected, Cultivated Red Seaweeds and Their Components in Combination with Tetracycline, against Poultry Pathogen Salmonella Enteritidis. JMSE 2020;8:511. [DOI: 10.3390/jmse8070511] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
13 Singh AP, Preet S, Rishi P. Nisin/β-lactam adjunct therapy against Salmonella enterica serovar Typhimurium: a mechanistic approach. Journal of Antimicrobial Chemotherapy 2014;69:1877-87. [DOI: 10.1093/jac/dku049] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
14 Thomas VM, Brown RM, Ashcraft DS, Pankey GA. Synergistic effect between nisin and polymyxin B against pandrug-resistant and extensively drug-resistant Acinetobacter baumannii. International Journal of Antimicrobial Agents 2019;53:663-8. [DOI: 10.1016/j.ijantimicag.2019.03.009] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 7.3] [Reference Citation Analysis]
15 Tenea GN, Hurtado P, Ortega C. A Novel Weissella cibaria Strain UTNGt21O Isolated from Wild Solanum quitoense Fruit: Genome Sequence and Characterization of a Peptide with Highly Inhibitory Potential toward Gram-Negative Bacteria. Foods 2020;9:E1242. [PMID: 32899506 DOI: 10.3390/foods9091242] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Özdemir FN, Buzrul S, Özdemir C, Akçelik N, Akçelik M. Determination of an effective agent combination using nisin against Salmonella biofilm. Arch Microbiol 2022;204:167. [PMID: 35133506 DOI: 10.1007/s00203-022-02766-4] [Reference Citation Analysis]
17 Kaur N, Dilawari R, Kaur A, Sahni G, Rishi P. Recombinant expression, purification and PEGylation of Paneth cell peptide (cryptdin-2) with value added attributes against Staphylococcus aureus. Sci Rep 2020;10:12164. [PMID: 32699335 DOI: 10.1038/s41598-020-69039-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
18 S S, S R. Cyclic peptide production from lactic acid bacteria (LAB) and their diverse applications. Crit Rev Food Sci Nutr 2020;:1-20. [PMID: 33356473 DOI: 10.1080/10408398.2020.1860900] [Reference Citation Analysis]
19 Ahmad V, Khan MS, Jamal QMS, Alzohairy MA, Al Karaawi MA, Siddiqui MU. Antimicrobial potential of bacteriocins: in therapy, agriculture and food preservation. International Journal of Antimicrobial Agents 2017;49:1-11. [DOI: 10.1016/j.ijantimicag.2016.08.016] [Cited by in Crossref: 117] [Cited by in F6Publishing: 80] [Article Influence: 23.4] [Reference Citation Analysis]
20 Lee B, Hwang J, Lee D. Antibacterial action of lactoferricin B like peptide against Escherichia coli : reactive oxygen species‐induced apoptosis‐like death. J Appl Microbiol 2020;129:287-95. [DOI: 10.1111/jam.14632] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
21 Singh AP, Prabha V, Rishi P. Synergism in dual functionality of cryptdin-2 in conjunction with antibiotics against Salmonella. Indian J Med Res 2016;144:761-70. [PMID: 28361830 DOI: 10.4103/ijmr.IJMR_850_14] [Reference Citation Analysis]
22 Rishi P, Thakur R, Kaur UJ, Singh H, Bhasin KK. Potential of 2, 2'-dipyridyl diselane as an adjunct to antibiotics to manage cadmium-induced antibiotic resistance in Salmonella enterica serovar Typhi Ty2 strain. J Microbiol 2017;55:737-44. [PMID: 28779338 DOI: 10.1007/s12275-017-7040-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
23 Kaur A, Chopra K, Kaur IP, Rishi P. Salmonella Strain Specificity Determines Post-typhoid Central Nervous System Complications: Intervention by Lactiplantibacillus plantarum at Gut-Brain Axis. Front Microbiol 2020;11:1568. [PMID: 32793135 DOI: 10.3389/fmicb.2020.01568] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
24 Ahire JJ, Neveling DP, Dicks LM. Co-spinning of Silver Nanoparticles with Nisin Increases the Antimicrobial Spectrum of PDLLA: PEO Nanofibers. Curr Microbiol 2015;71:24-30. [PMID: 25855302 DOI: 10.1007/s00284-015-0813-y] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.9] [Reference Citation Analysis]
25 Maaß S, Bartel J, Mücke PA, Schlüter R, Sura T, Zaschke-Kriesche J, Smits SHJ, Becher D. Proteomic Adaptation of Clostridioides difficile to Treatment with the Antimicrobial Peptide Nisin. Cells 2021;10:372. [PMID: 33670309 DOI: 10.3390/cells10020372] [Reference Citation Analysis]
26 Ahire JJ, Dicks LM. Nisin Incorporated With 2,3-Dihydroxybenzoic Acid in Nanofibers Inhibits Biofilm Formation by a Methicillin-Resistant Strain of Staphylococcus aureus. Probiotics Antimicrob Proteins 2015;7:52-9. [PMID: 25319566 DOI: 10.1007/s12602-014-9171-5] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 6.0] [Reference Citation Analysis]
27 Rishi P, Bhagat NR, Thakur R, Pathania P. Tackling Salmonella Persister Cells by Antibiotic-Nisin Combination via Mannitol. Indian J Microbiol 2018;58:239-43. [PMID: 29651185 DOI: 10.1007/s12088-018-0713-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
28 Huang F, Teng K, Liu Y, Cao Y, Wang T, Ma C, Zhang J, Zhong J. Bacteriocins: Potential for Human Health. Oxid Med Cell Longev 2021;2021:5518825. [PMID: 33936381 DOI: 10.1155/2021/5518825] [Reference Citation Analysis]
29 Shin JM, Gwak JW, Kamarajan P, Fenno JC, Rickard AH, Kapila YL. Biomedical applications of nisin. J Appl Microbiol 2016;120:1449-65. [PMID: 26678028 DOI: 10.1111/jam.13033] [Cited by in Crossref: 201] [Cited by in F6Publishing: 169] [Article Influence: 33.5] [Reference Citation Analysis]
30 Dey DK, Khan I, Kang SC. Anti-bacterial susceptibility profiling of Weissella confusa DD_A7 against the multidrug-resistant ESBL-positive E. coli. Microbial Pathogenesis 2019;128:119-30. [DOI: 10.1016/j.micpath.2018.12.048] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
31 Jindal HM, Zandi K, Ong KC, Velayuthan RD, Rasid SM, Samudi Raju C, Sekaran SD. Mechanisms of action and in vivo antibacterial efficacy assessment of five novel hybrid peptides derived from Indolicidin and Ranalexin against Streptococcus pneumoniae. PeerJ 2017;5:e3887. [PMID: 29018620 DOI: 10.7717/peerj.3887] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
32 Kaur A, Chabba SK, Kaur UJ, Kaur A, Preet S, Rishi P. Management of Staphylococcus Mediated Systemic Infection by Enhancing the Resurging Activity of Co-trimoxazole in Presence of Cryptdin-2. Indian J Microbiol 2017;57:438-47. [PMID: 29151645 DOI: 10.1007/s12088-017-0672-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]